
ASCO 2026 Highlights
Jul 31, 2026 - 00:33:35
Radio and PodcastLive Radio & Podcasts
Tumor-infiltrating lymphocyte, or TIL, therapy is a new form of cellular immunotherapy that targets cancer cells by leveraging the body’s immune system and specialized cells called T-lymphocytes. This treatment is curren...
Tumor-Infiltrating Lymphocytes (TIL) & Melanoma: A New Era of Treatment is an episode from CancerCast by Weill Cornell Medicine. Tumor-infiltrating lymphocyte, or TIL, therapy is a new form of cellular immunotherapy that targets cancer cell...
This episode belongs to CancerCast.
Use the player on this page to stream the episode online.
Published Sep 22, 2025, audio available.